Last Updated: September 28, 2026

TESTODERM Drug Patent Profile

✉ Email this page to a colleague

When do Testoderm patents expire, and what generic alternatives are available?

Testoderm is a drug marketed by Alza and is included in two NDAs.

The generic ingredient in TESTODERM is testosterone. Sixteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Testoderm

A generic version of TESTODERM was approved as testosterone by ACTAVIS LABS UT INC on January 27^th, 2006.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TESTODERM?
What are the global sales for TESTODERM?
What is Average Wholesale Price for TESTODERM?

Summary for TESTODERM

US Patents:	0
Applicants:	1
NDAs:	2

US Patents and Regulatory Information for TESTODERM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alza	TESTODERM	testosterone	FILM, EXTENDED RELEASE;TRANSDERMAL	019762-001	Oct 12, 1993		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alza	TESTODERM	testosterone	FILM, EXTENDED RELEASE;TRANSDERMAL	019762-002	Oct 12, 1993		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alza	TESTODERM TTS	testosterone	FILM, EXTENDED RELEASE;TRANSDERMAL	020791-001	Dec 18, 1997		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for TESTODERM

See the table below for patents covering TESTODERM around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Canada	1257819	DISPOSITIF POUR LA DISPENSATION DE MEDICAMENTS PAR VOIE TRANSDERMALE (TRANSDERMAL DRUG DELIVERY DEVICE)	⤷ Start Trial
Germany	3523065	Therapeutisches Abgabesystem	⤷ Start Trial
Germany	3687067		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.